Publication
Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review.
Journal Paper/Review - Apr 5, 2024
Dittrich Tolga, Vock Dominik, Fisch Urs, Hert Lisa, Baumann Sira M, Kliem Paulina S C, Rüegg Stephan, Marsch Stephan C, De Marchis Gian Marco, Sutter Raoul
Units
PubMed
Doi
Contact
Citation
Dittrich T, Vock D, Fisch U, Hert L, Baumann S, Kliem P, Rüegg S, Marsch S, De Marchis G, Sutter R. Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review. Neurocrit Care 2024
Type
Journal Paper/Review (English)
Journal
Neurocrit Care 2024
Publication Date
Apr 5, 2024
Issn Electronic
1556-0961
Brief description/objective
The objective of this study was to assess the efficacy and tolerability of intranasal midazolam (in-MDZ) administration for antiseizure treatment in adults.